News – Page 398 – Endpoints News

Pfizer invests in Ribon Therapeutics; Argenx gets PDUFA date extension

3 years ago

Alto Neuroscience bags $25M for four Phase II drugs

3 years ago

Pfizer-backed decentralized cooperative raises $4.1M to fund longevity research

3 years ago

Eric Lander to return to Broad Institute, one year after White House exit over bullying allegations

3 years ago

FDA approves Italy-based pharma's oral SERD for some breast cancer patients

3 years ago

Updated: $100B+ in savings? Why the incoming Humira biosimilars will take time to catch on

3 years ago

Amgen lays off about 300 workers, citing 'industry headwinds'

3 years ago

Late Friday approval; Trio of biotechs wind down; Stem cell pioneer finds new frontier; Biotech icon to retire; and ...

3 years ago

Bristol Myers, Charles River join Series A funding for iVexSol

3 years ago

Updated: Samsung Biologics spells out expansion plans in South Korea and US

3 years ago

Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma

3 years ago

Novartis' approved sickle cell disease drug fails to beat placebo in PhIII

3 years ago

Sen. Elizabeth Warren urges FTC to 'scrutinize' two pharma buyouts

3 years ago

Kidney disease drugmaker Goldfinch Bio shuts down

3 years ago

UCB, Novo Nordisk, Gilead rank highest among pharmas for HCP customer experience — survey

3 years ago

Novavax gets ready to take another shot at Covid vaccine market with next season plans

3 years ago

Post-hoc analysis: EMA's CHMP rejects Ipsen's potential drug for rare genetic disease

3 years ago

FDA approves another indication for Keytruda, this time in the adjuvant NSCLC setting

3 years ago

BridgeBio company sells off rare disease candidate to Galderma partner

3 years ago

Four years in, Sana gets first FDA go-ahead to bring cancer treatment into the clinic

3 years ago

J&J, Legend say Carvykti beat standard therapy in earlier-line blood cancer

3 years ago

Dutch biotech starts liquidation after ending PhIII in GVHD

3 years ago

Pfizer lays off employees at California and Connecticut sites

3 years ago

#JPM23: BeiGene CEO John Oyler on the company's big ambitions

3 years ago

First page Previous page 395 396 397398399 400 401 Next page Last page